A virologist breaks down everything you need to know about the UK variant.
Academic rigour, journalistic flair
Articles on COVID-19 vaccines
Displaying 381 - 400 of 576 articles
There is a difference between people who deliberately seek out vaccines outside the system, and those who are offered them because they’re about to expire.
From Queen Elizabeth to Willie Nelson, celebrities have long used their platforms to promote public health information. Why do people trust celebrities for health advice more than the government?
With four COVID-19 vaccines approved for use in Canada, it’s time to answer FAQs about efficacy, immunity, eradication and variants.
One important metric by which we can measure the success of our public health system: Ensuring everyone has access to immunization in their community.
As New Zealand prepares to roll out COVID-19 vaccines to the general population, health authorities will need to reach those who remain hesitant through information sources they trust.
Even if you’re vaccinated, you still need to come forward for COVID testing, even if you have the mildest symptoms.
Religious opposition over a link to abortions performed decades ago and misunderstandings about effectiveness could lead to a nightmare of angry patients and wasted vaccine.
Immunity fades rapidly for some infections (influenza) but lasts a lifetime with others (measles). Here’s what we know about COVID.
Italy’s decision to block export of AstraZeneca vaccines to Australia will likely not impact our vaccine roll-out. But vaccine scarcity is a looming problem in other parts of the world.
The FDA has indicated booster shots, to cover coronavirus variants, won’t need to go through lengthy phase 3 clinical trials. Instead, they can be tested in smaller trials, which will save time.
South Africa’s constitutional values of good public governance and transparency in public procurement have been sacrificed in the process of buying COVID-19 vaccines.
Real-world studies of vaccines aren’t directly comparable with clinical trials, but their results are still good news.
South Africa is aiming for 67% coverage, which translates to about 40 million people by the end of 2021.
Most of us don’t know yet when or where we’ll receive our COVID vaccination. But particularly as there’s a risk of scams, it’s important to be clear on how this process will (and won’t) play out.
In a digital age, and with unequal access to vaccines, there are considerable potential downsides to so-called ‘vaccine passports’.
Our new research found gaps in COVID information available to culturally and linguistically diverse communities. But there are ways we can improve — because community ownership is crucial.
Fair global agreements, home-grown vaccines and sharing extra doses with poorer nations are all needed if we’re to ever emerge from this pandemic.
For elite athletes, even mild COVID-19 vaccine side effects can throw their training plans off course. But they can plan ahead.
To make sure the COVID rollout is accessible to all people living in Australia, the government should consider a migrant amnesty.
Job Board
-
Program Manager, Teaching & Learning Initiatives
-
Lecturer/Senior Lecturer, Earth System Science (School of Science)
-
Sydney Horizon Educators (Identified)
-
Deputy Social Media Producer
-
Associate Professor, Occupational Therapy
Top contributors
-
Associate professor, UNSW Sydney
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Early Career Research Leader, Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University
-
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute
-
Associate Professor, School of Social Sciences, The University of Western Australia
-
Associate Professor and ARC Future Fellow, The University of Western Australia
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Associate Professor, Epidemiology, Deakin University
-
Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
-
Assistant Professor of Political Science, Oklahoma State University
-
Instructor of Human Immunology, Emory University
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Immunology, Vice-Chancellors Distinguished Professorial Fellow, Head of Immunology and Translational Research, Victoria University
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Chair in Epidemiology, Deakin University
